S. Ostrand-Rosenberg

Immunology · 2000–2018

A researcher in the Science corpus: 10 papers; trusts 12 researchers and is trusted by 20 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 209 citations into it; #179 of 2,160 by trust here, #246 by citations
• Oncology — 107 citations into it; #219 of 1,698 by trust here, #486 by citations
• Molecular Biology — 53 citations into it

Whom S. Ostrand-Rosenberg trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Gabrilovich
2. V. Bronte
3. P. Sinha
4. A. Sica
5. P. Serafini
6. A. Mantovani
7. S. Nagaraj
8. P. Rodriguez
9. M. Markiewski
10. F. Balkwill

Who trusts S. Ostrand-Rosenberg overall

1. D. Hanahan
2. D. Gabrilovich
3. Y. Pylayeva-Gupta
4. R. Weinberg
5. Cesar A. Corzo
6. Swarnali Acharyya
7. T. Condamine
8. Vinit Kumar
9. Kyoung Eun Lee
10. Je-in Youn

Papers from S. Ostrand-Rosenberg's perspective

Ordered by how strongly the researchers S. Ostrand-Rosenberg trusts endorse each paper. Same corpus, a different order for every researcher.

1. Altered macrophage differentiation and immune dysfunction in tumor development. (Journal of Clinical Investigation)
2. Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
3. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. (Cancer Cell)
4. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein (Journal of Experimental Medicine)
5. The terminology issue for myeloid-derived suppressor cells. (Cancer Research)
6. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 (Journal of Immunology)
7. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (Journal of Experimental Medicine)
8. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (Journal of Immunology)
9. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. (Blood)
10. Regulation of immune responses by L-arginine metabolism (Nature reviews. Immunology)

Their papers

• Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells (2008) — 740 citations
• Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) — 5,098 citations
• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards (2016) — 2,457 citations
• Coordinated regulation of myeloid cells by tumours (2012) — 3,493 citations
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer (2009) — 1,555 citations
• Myeloid-derived Suppressor Cells Inhibit T Cell Activation by Depleting Cystine and Cysteine (2009) — 921 citations
• Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. (2007) — 754 citations
• The terminology issue for myeloid-derived suppressor cells. (2007) — 809 citations
• Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. (2007) — 669 citations
• Mouse 4T1 Breast Tumor Model (2000) — 882 citations